Cornell Pochily Investment Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,315
| Closed | -$224K | – | 179 |
|
2025
Q1 | $224K | Sell |
1,315
-135
| -9% | -$23K | 0.08% | 157 |
|
2024
Q4 | $241K | Sell |
1,450
-111
| -7% | -$18.4K | 0.08% | 151 |
|
2024
Q3 | $268K | Sell |
1,561
-20
| -1% | -$3.44K | 0.09% | 154 |
|
2024
Q2 | $244K | Sell |
1,581
-66
| -4% | -$10.2K | 0.09% | 150 |
|
2024
Q1 | $253K | Sell |
1,647
-45
| -3% | -$6.92K | 0.1% | 151 |
|
2023
Q4 | $267K | Sell |
1,692
-20
| -1% | -$3.16K | 0.11% | 150 |
|
2023
Q3 | $251K | Sell |
1,712
-75
| -4% | -$11K | 0.11% | 152 |
|
2023
Q2 | $274K | Sell |
1,787
-125
| -7% | -$19.1K | 0.11% | 150 |
|
2023
Q1 | $296K | Sell |
1,912
-20
| -1% | -$3.1K | 0.13% | 141 |
|
2022
Q4 | $298K | Sell |
1,932
-65
| -3% | -$10K | 0.13% | 138 |
|
2022
Q3 | $264K | Buy |
1,997
+25
| +1% | +$3.31K | 0.12% | 142 |
|
2022
Q2 | $267K | Hold |
1,972
| – | – | 0.12% | 145 |
|
2022
Q1 | $294K | Sell |
1,972
-145
| -7% | -$21.6K | 0.11% | 143 |
|
2021
Q4 | $343K | Sell |
2,117
-100
| -5% | -$16.2K | 0.13% | 134 |
|
2021
Q3 | $368K | Sell |
2,217
-41
| -2% | -$6.81K | 0.16% | 130 |
|
2021
Q2 | $390K | Sell |
2,258
-58
| -3% | -$10K | 0.17% | 123 |
|
2021
Q1 | $372K | Sell |
2,316
-100
| -4% | -$16.1K | 0.18% | 117 |
|
2020
Q4 | $406K | Sell |
2,416
-87
| -3% | -$14.6K | 0.2% | 101 |
|
2020
Q3 | $394K | Buy |
2,503
+92
| +4% | +$14.5K | 0.23% | 97 |
|
2020
Q2 | $404K | Buy |
2,411
+15
| +0.6% | +$2.51K | 0.25% | 92 |
|
2020
Q1 | $314K | Sell |
2,396
-64
| -3% | -$8.39K | 0.23% | 98 |
|
2019
Q4 | $365K | Sell |
2,460
-6
| -0.2% | -$890 | 0.22% | 103 |
|
2019
Q3 | $305K | Sell |
2,466
-174
| -7% | -$21.5K | 0.2% | 110 |
|
2019
Q2 | $372 | Buy |
2,640
+349
| +15% | +$49 | 0.09% | 107 |
|
2019
Q1 | $345K | Buy |
2,291
+21
| +0.9% | +$3.16K | 0.24% | 97 |
|
2018
Q4 | $282K | Buy |
2,270
+409
| +22% | +$50.8K | 0.18% | 110 |
|
2018
Q3 | $294K | Buy |
1,861
+95
| +5% | +$15K | 0.2% | 108 |
|
2018
Q2 | $247K | Buy |
1,766
+238
| +16% | +$33.3K | 0.17% | 113 |
|
2018
Q1 | $203K | Buy |
+1,528
| New | +$203K | 0.14% | 125 |
|